Dualyx is a Ghent-based biotech company that develops novel Treg-based therapies for patients with difficult-to-treat autoimmune diseases. The company was founded in 2020 by Luc van Rompaey in collaboration with Wurzburg University, Argenx, VIB, Ghent University and KU Leuven.

Dualyx

dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases.
We aim to create long-lasting treatments for patients with a high unmet medical need.

Gemma Frisius Fund

Andera Partners

Forbion Capital Partners

BioGeneration Ventures

V-Bio Ventures

Fountain Healthcare Partners

HTGF | High-Tech Gruenderfonds

Font Awesome

Mobile Non Scaleable Content

Google

Google Cloud

Juliette Audet

Aneta Sottil

Ena Prosser

Europe Early Stage Companies With Fewer Than 1000 Employees

Europe, Middle East, and Africa (EMEA) Startups (Top 10K)

Europe Companies With Fewer Than 1000 Employees (Top 10K)

European Union (EU) Health Care Companies (Top 10K)

Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.

Series A - Dualyx

Venture Round - Dualyx

Ghent

Oost-Vlaanderen

Belgium

Europe

'The fundamentals are really strong': Why investors are staying ...

EUVC #223 Juliette Audet, Partner at Forbion

Genesis $200 million richer as first AI-enabled drug ...

The 10 most active techbio investors in Europe

Belgian startups hit rock bottom in funding as venture capital ...

Fountain Healthcare co-leads Dualyx’s €40m fundraise

Dualyx raises 40 million euros to progress Treg therapies

Autoimmune disease company Dualyx raises $43.5M in series A

The Netherlands

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 25, 2024 7:41 PM	c555fbb0
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:50 PM	ad9eeca7
crunchbase profile	general	Oct 29, 2024 9:14 AM	6fe08d82
li profile	general	Aug 25, 2024 7:41 PM	6ddd1467
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	d348ac38
peers	general	Aug 25, 2024 7:41 PM	1ad6767b
news basic	general	Aug 25, 2024 7:41 PM	8026e4ab
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

DUAL

COM:DUALYX

Dualyx